Monoclonal antibodies (mAbs) have become the most growth-accelerated segment of the biopharmaceutical industry, with advanced molecular engineering and antibody humanization making it possible to ...

MINNEAPOLIS, July 28, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 ...

The advent of gene therapy has unlocked new possibilities for treating diseases previously regarded as intractable. However, producing adeno-associated virus (AAV)-mediated gene therapy products ...

In a recent study posted to the medRxiv* preprint server, the researchers investigated the effect of binding antibodies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases. The ...

Gene therapy is a rapidly growing area for therapeutic development, due to the potential to cure a wide range of genetic disorders. Although gene therapy has been around for many years, advances in ...

The GeneSwift Assay kit from Gator Bio delivers results in just 35 minutes using most undiluted bioprocess samples. Gator Bio's GeneSwift assays combine a highly specific, single DNA hybridization, ...

Simple Plex AAV assays combine industry leading AAV antibody reagents from PROGEN with convenience and simplicity of the fully automated Ella platform. MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ -- ...

Cell viability assays such as Cell Titer Blue and Alamar Blue rely on the reducing property of viable cells and are commonly used as a screening method to determine the cytotoxic potential of drugs ...

Background. The phase III Zostavax Efficacy and Safety Trial of 1 dose of licensed zoster vaccine (ZV; Zostavax; Merck) in 50-59-year-olds showed approximately 70% vaccine efficacy (VE) to reduce the ...